CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 217 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $6,902,000 | -31.0% | 235,000 | +6.8% | 0.84% | -40.0% |
| Q2 2018 | $10,003,000 | +6.7% | 220,000 | +23.9% | 1.40% | -15.1% |
| Q1 2018 | $9,372,000 | +8.1% | 177,500 | +39.2% | 1.65% | -21.9% |
| Q4 2017 | $8,670,000 | -17.5% | 127,500 | 0.0% | 2.11% | -28.9% |
| Q3 2017 | $10,506,000 | -13.7% | 127,500 | -1.9% | 2.97% | -34.1% |
| Q2 2017 | $12,172,000 | +731.4% | 130,000 | +465.2% | 4.50% | +421.1% |
| Q1 2017 | $1,464,000 | -63.1% | 23,000 | -79.1% | 0.86% | -73.1% |
| Q3 2016 | $3,966,000 | +92.7% | 110,000 | -26.7% | 3.21% | +56.8% |
| Q2 2016 | $2,058,000 | – | 150,000 | – | 2.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |